Atara Biotherapeutics Inc
Change company Symbol lookup
Select an option...
ATRA Atara Biotherapeutics Inc
UGRO Urban-Gro Inc
ACIU AC Immune SA
KPRX Kiora Pharmaceuticals Inc
ATIF ATIF Holdings Ltd
BHR Braemar Hotels & Resorts Inc
QTEKW QualTek Services Equity Warrant Exp 14th Feb 2027 *W EXP 02/14/2027
ALR Alerislife Inc
CCEP Coca-Cola Europacific Partners PLC
QQQ Invesco QQQ Trust
Go

Health Care : Biotechnology | Small Cap Value
Company profile

Atara Biotherapeutics, Inc. is an allogeneic T-cell immunotherapy company. The Company is a developer of T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune disease. Its platform leverages the biology of EBV T cells and has the capability to treat a range of EBV-driven diseases or other serious diseases through engineered chimeric antigen receptors (CARs) or T-cell receptors (TCRs). The Company’s pipeline products include Tab-cel, ATA188, ATA2271, ATA3271 and ATA3219. The Company’s T-cell immunotherapy, tab-cel (tabelecleucel), is in Phase III development for patients with EBV-driven post-transplant lymphoproliferative disease (EBV+ PTLD) who have failed rituximab or rituximab plus chemotherapy, as well as other EBV-driven diseases. Its ATA188 is a T-cell immunotherapy for the treatment of multiple sclerosis.

Closing Price
$4.72
Day's Change
-0.22 (-4.45%)
Bid
--
Ask
--
B/A Size
--
Day's High
5.02
Day's Low
4.64
Volume
(Light)
Volume:
1,404,432

10-day average volume:
3,885,657
1,404,432
  • Prev Close
    4.94
  • Today's Open
    4.86
  • Day's Range
    4.64-5.02
  • Avg Vol (10-day)
    3.9M
  • Last (time)
    4:00p ET 08/17/22
  • Last (size)
    1
  • 52-Wk Range
    2.83 - 20.04
    LowHigh
  • (11/04/21 - 08/01/22)
    66.78%
  • 117.7%
  • Market Cap
    445.4M
  • Shares Outstanding
    94.4M
  • -2.56
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.1
  • 97.10
  • (% of float 07/29/22)
    11.36

Latest News

August 15, 2022
9:00 pm ET
Globe Newswire
August 08, 2022
4:01 pm ET
BusinessWire
August 05, 2022
9:00 pm ET
Globe Newswire
9:00 pm ET
BusinessWire
August 04, 2022
9:00 pm ET
BusinessWire
4:01 pm ET
BusinessWire
August 03, 2022
4:01 pm ET
BusinessWire
12:45 pm ET
Accesswire
August 01, 2022
4:01 pm ET
BusinessWire
July 28, 2022
5:18 pm ET
BusinessWire
July 13, 2022
6:51 am ET
MarketWatch
July 12, 2022
4:30 pm ET
BusinessWire
July 06, 2022
4:01 pm ET
BusinessWire
July 01, 2022
7:57 pm ET
BusinessWire
June 04, 2022
9:00 am ET
BusinessWire
June 03, 2022
4:01 pm ET
BusinessWire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.